Delivery Order SPE2DB20D2104-SPE2DB25FMSVM
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,336.32 to AmerisourceBergen Drug Corp for Loestrin 21 1.5-30 tablets (21-tablet supply) on July 31, 2025, with ultimate completion by August 1, 2025. This is a firm fixed price, non-set-aside delivery order supporting federal pharmaceutical procurement requirements. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfilled the order from its corporate office location in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,718.66 to AmerisourceBergen Drug Corp on July 17, 2025, for the supply of Loestrin 21 1.5-30 tablets (21-count packages). This is a firm fixed-price, non-set-aside contract with a completion date of July 18, 2025, with performance occurring at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen, a major pharmaceutical distributor, is executing this order as a child contract under its broader...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,816.41 to AmerisourceBergen Drug Corp for the supply of Loestrin 21 1.5-30 tablets (21-count package). The contract, awarded on August 19, 2025, with an ultimate completion date of August 20, 2025, is a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office...
- The Defense Logistics Agency awarded a $3,121.57 delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Loestrin 21 1.5-30 tablets (21-count packages). This is a firm fixed price delivery order with no set-aside designation, representing a competitively awarded contract. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 19, 2025. This award is...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for Loestrin 21 1-20 Tablet in quantities of 21 tablets, with a contract ceiling value of $2,983.50 and a firm fixed price structure. The contract is non-set-aside and represents a competitive award for pharmaceutical supply. This delivery order is completed by July 31, 2025, and will be performed at the contractor's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Loestrin 21 1.5-30 tablets (21-count packaging) under a firm fixed-price contract valued at $2,010.11. This competitively awarded, non-set-aside delivery order is scheduled for completion by September 18, 2025, with performance to be fulfilled from the contractor's Conshohocken, Pennsylvania location. The award represents a child contract action under...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Loestrin 21 1-20 tablets in quantities of 21 units. This is a firm fixed-price delivery order with a ceiling value of $47,164.04 and a completion date of September 8, 2025. The award was made through open competition with no set-aside designation, and the place of performance is located in Conshohocken, Pennsylvania, which serves as...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Loestrin 21 1-20 Tablet in quantities of 21 units. This is a firm fixed-price delivery order with a ceiling value of $1,790.10 and an ultimate completion date of August 15, 2025. The contract was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform all work at...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Loestrin 21 1-20 tablets (21-count packages) under a firm fixed-price contract with a ceiling value of $3,580.26. This non-competitive delivery order is expected to be completed by August 11, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $2,133.43 to AmerisourceBergen Drug Corp for Loestrin 21 1-20 tablets (21-count packages) on September 15, 2025, with completion scheduled for September 16, 2025. This firm fixed-price delivery order, which carried no set-aside designation, will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The award represents a child contract under a larger Indefinite Delivery Contract vehicle. This...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FMSVMDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Loestrin 21 1.5-30 tablets (21-count packages) valued at $8,991.35 under a firm fixed-price contract type. The award, announced on June 9, 2025, with an ultimate completion date of June 10, 2025, represents a competitive procurement with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location, supplying this pharmaceutical product to support federal medical procurement needs. This delivery order operates as a child contract under AmerisourceBergen Drug Corp's significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications and medical supplies to military healthcare programs and other government healthcare systems, including the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen Drug Corp's extensive federal contract portfolio demonstrates its established capability as a major pharmaceutical distributor meeting federal medical supply requirements through open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.0k | 6/9/25 |